Ya-Wei Qiang received her M.D. degree from Xian Jiaotong University School of Medicine, Xian, China, and her Ph.D. degree from Chiba University School of Medicine, Chiba, Japan. She completed her Postdoctoral Fellowship at the National Institutes of Health, Bethesda, Md, USA, and she now serves as an Assistant Professor of medicine at the Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Ark, USA. Dr. Qiang has coauthored a book chapter and many publications in peer-reviewed journals, she has presented her research at numerous national and international meetings and conferences, and she is the inventor of three patents. She actively participates in peer review of manuscripts for a number of journals and is also a Reviewer of grant applications to the American Cancer Society and international private foundations. Her numerous awards include the 2006 Senior Investigator Award and the 2010 Myeloma Microenvironment Award from the Multiple Myeloma Research Foundation, a fellowship award from the National Institutes of Health, and the Award for Research Excellence from the National Cancer Institute. Dr. Qiang's current research focuses on understanding the molecular pathogenesis of multiple myeloma. Her seminal contributions to myeloma research include dissecting the involvement of the IGF-I-activated MAPK and PI3K/AKT pathways in myeloma growth and migration, identifying Wnt signaling in myeloma pathogenesis, and elucidating the molecular mechanisms underlying the roles of proteasome inhibitors in regulating differentiation of mesenchymal stem cells in multiple myeloma.
Biography Updated on 8 November 2013